PropertyValue
?:abstract
  • With the major spread of SARS-COV-2 around the world, its association with various pathologies has been reported. However, hemopathy has rarely been revealed during a coronavirus infection. The authors of this article aim to emphasize the diagnostic and therapeutic challenges faced while treating COVID/hemopathy patients.
is ?:annotates of
?:creator
?:doi
  • 10.11604/pamj.2020.36.286.24361
?:doi
?:journal
  • Pan_Afr_Med_J
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/d4e03ca991291cb51dbbfe376b9a60765195bb06.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7572674.xml.json
?:pmcid
?:pmid
?:pmid
  • 33117480.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges
?:type
?:year
  • 2020-08-17

Metadata

Anon_0  
expand all